List of Excipients in API hydroxychloroquine sulfate
Excipients in NDA-approved (novel) drugs containing hydroxychloroquine sulfate
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Aphena Pharma Solutions - Tennessee LLC | HYDROXYCHLOROQUINE SULFATE | hydroxychloroquine sulfate | 43353-051 | CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | |
| Aphena Pharma Solutions - Tennessee LLC | HYDROXYCHLOROQUINE SULFATE | hydroxychloroquine sulfate | 43353-051 | CARNAUBA WAX | |
| Aphena Pharma Solutions - Tennessee LLC | HYDROXYCHLOROQUINE SULFATE | hydroxychloroquine sulfate | 43353-051 | FERROSOFERRIC OXIDE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing hydroxychloroquine sulfate
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Teva Pharmaceuticals USA Inc | hydroxychloroquine sulfate | 0093-2401 | CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE |
| Teva Pharmaceuticals USA Inc | hydroxychloroquine sulfate | 0093-2401 | HYPROMELLOSE 2910 |
| Teva Pharmaceuticals USA Inc | hydroxychloroquine sulfate | 0093-2401 | MAGNESIUM STEARATE |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for hydroxychloroquine sulfate
Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE
hydroxychloroquine sulfate drug variants containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
| Company | Ingredient | NDC |
|---|---|---|
| Sandoz Inc | hydroxychloroquine sulfate | 0781-1407 |
| Sandoz Inc | hydroxychloroquine sulfate | 0781-5994 |
| Major Pharmaceuticals | hydroxychloroquine sulfate | 0904-6884 |
| >Company | >Ingredient | >NDC |
hydroxychloroquine sulfate drug variants not containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | hydroxychloroquine sulfate | 0093-2401 |
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| >Company | >Ingredient | >NDC |
Excipient focus: ANHYDROUS LACTOSE
hydroxychloroquine sulfate drug variants containing ANHYDROUS LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| Mylan Institutional Inc | hydroxychloroquine sulfate | 42292-011 |
| Aurobindo Pharma Limited | hydroxychloroquine sulfate | 59651-889 |
| >Company | >Ingredient | >NDC |
hydroxychloroquine sulfate drug variants not containing ANHYDROUS LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | hydroxychloroquine sulfate | 0093-2401 |
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| NCS HealthCare of KY Inc dba Vangard Labs | hydroxychloroquine sulfate | 0615-8325 |
| >Company | >Ingredient | >NDC |
Excipient focus: CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
hydroxychloroquine sulfate drug variants containing CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| Aphena Pharma Solutions - Tennessee LLC | hydroxychloroquine sulfate | 43353-051 |
| Advanz Pharma (US) Corp | hydroxychloroquine sulfate | 59212-562 |
| Prasco Laboratories | hydroxychloroquine sulfate | 66993-057 |
| >Company | >Ingredient | >NDC |
hydroxychloroquine sulfate drug variants not containing CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | hydroxychloroquine sulfate | 0093-2401 |
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| >Company | >Ingredient | >NDC |
Excipient focus: CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE
hydroxychloroquine sulfate drug variants containing CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | hydroxychloroquine sulfate | 0093-2401 |
| NCS HealthCare of KY LLC dba Vangard Labs | hydroxychloroquine sulfate | 0615-8374 |
| A-S Medication Solutions | hydroxychloroquine sulfate | 50090-4659 |
| >Company | >Ingredient | >NDC |
hydroxychloroquine sulfate drug variants not containing CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| NCS HealthCare of KY Inc dba Vangard Labs | hydroxychloroquine sulfate | 0615-8325 |
| >Company | >Ingredient | >NDC |
Excipient focus: CARNAUBA WAX
hydroxychloroquine sulfate drug variants containing CARNAUBA WAX
| Company | Ingredient | NDC |
|---|---|---|
| Aphena Pharma Solutions - Tennessee LLC | hydroxychloroquine sulfate | 43353-051 |
| A-S Medication Solutions | hydroxychloroquine sulfate | 50090-3432 |
| Advanz Pharma (US) Corp | hydroxychloroquine sulfate | 59212-562 |
| >Company | >Ingredient | >NDC |
hydroxychloroquine sulfate drug variants not containing CARNAUBA WAX
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | hydroxychloroquine sulfate | 0093-2401 |
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
hydroxychloroquine sulfate drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| NCS HealthCare of KY Inc dba Vangard Labs | hydroxychloroquine sulfate | 0615-8325 |
| >Company | >Ingredient | >NDC |
hydroxychloroquine sulfate drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | hydroxychloroquine sulfate | 0093-2401 |
| NCS HealthCare of KY LLC dba Vangard Labs | hydroxychloroquine sulfate | 0615-8374 |
| NCS HealthCare of KY LLC dba Vangard Labs | hydroxychloroquine sulfate | 0615-8401 |
| >Company | >Ingredient | >NDC |
Excipient focus: CI 77891
hydroxychloroquine sulfate drug variants containing CI 77891
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | hydroxychloroquine sulfate | 50090-5573 |
| >Company | >Ingredient | >NDC |
hydroxychloroquine sulfate drug variants not containing CI 77891
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | hydroxychloroquine sulfate | 0093-2401 |
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
hydroxychloroquine sulfate drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| Mylan Institutional Inc | hydroxychloroquine sulfate | 42292-011 |
| A-S Medication Solutions | hydroxychloroquine sulfate | 50090-4659 |
| >Company | >Ingredient | >NDC |
hydroxychloroquine sulfate drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | hydroxychloroquine sulfate | 0093-2401 |
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| NCS HealthCare of KY Inc dba Vangard Labs | hydroxychloroquine sulfate | 0615-8325 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
hydroxychloroquine sulfate drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | hydroxychloroquine sulfate | 0904-7046 |
| Rising Pharma Holdings Inc | hydroxychloroquine sulfate | 16571-687 |
| Laurus Labs Limited | hydroxychloroquine sulfate | 42385-927 |
| >Company | >Ingredient | >NDC |
hydroxychloroquine sulfate drug variants not containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | hydroxychloroquine sulfate | 0093-2401 |
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| >Company | >Ingredient | >NDC |
Excipient focus: DEXTRATES
hydroxychloroquine sulfate drug variants containing DEXTRATES
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| NCS HealthCare of KY Inc dba Vangard Labs | hydroxychloroquine sulfate | 0615-8325 |
| A-S Medication Solutions | hydroxychloroquine sulfate | 50090-2508 |
| >Company | >Ingredient | >NDC |
hydroxychloroquine sulfate drug variants not containing DEXTRATES
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | hydroxychloroquine sulfate | 0093-2401 |
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| NCS HealthCare of KY LLC dba Vangard Labs | hydroxychloroquine sulfate | 0615-8374 |
| >Company | >Ingredient | >NDC |
Excipient focus: DIBASIC CALCIUM PHOSPHATE DIHYDRATE
hydroxychloroquine sulfate drug variants containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | hydroxychloroquine sulfate | 0615-8459 |
| Northstar Rx LLC | hydroxychloroquine sulfate | 16714-110 |
| A-S Medication Solutions | hydroxychloroquine sulfate | 50090-6629 |
| >Company | >Ingredient | >NDC |
hydroxychloroquine sulfate drug variants not containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | hydroxychloroquine sulfate | 0093-2401 |
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
hydroxychloroquine sulfate drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Bryant Ranch Prepack | hydroxychloroquine sulfate | 63629-4465 |
| >Company | >Ingredient | >NDC |
hydroxychloroquine sulfate drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | hydroxychloroquine sulfate | 0093-2401 |
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
hydroxychloroquine sulfate drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Aphena Pharma Solutions - Tennessee LLC | hydroxychloroquine sulfate | 43353-051 |
| A-S Medication Solutions | hydroxychloroquine sulfate | 50090-3432 |
| Advanz Pharma (US) Corp | hydroxychloroquine sulfate | 59212-562 |
| >Company | >Ingredient | >NDC |
hydroxychloroquine sulfate drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | hydroxychloroquine sulfate | 0093-2401 |
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
hydroxychloroquine sulfate drug variants containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Sandoz Inc | hydroxychloroquine sulfate | 0781-1407 |
| Sandoz Inc | hydroxychloroquine sulfate | 0781-5994 |
| Major Pharmaceuticals | hydroxychloroquine sulfate | 0904-6884 |
| >Company | >Ingredient | >NDC |
hydroxychloroquine sulfate drug variants not containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | hydroxychloroquine sulfate | 0093-2401 |
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
hydroxychloroquine sulfate drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| NCS HealthCare of KY Inc dba Vangard Labs | hydroxychloroquine sulfate | 0615-8325 |
| >Company | >Ingredient | >NDC |
hydroxychloroquine sulfate drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | hydroxychloroquine sulfate | 0093-2401 |
| NCS HealthCare of KY LLC dba Vangard Labs | hydroxychloroquine sulfate | 0615-8374 |
| NCS HealthCare of KY LLC dba Vangard Labs | hydroxychloroquine sulfate | 0615-8401 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2910
hydroxychloroquine sulfate drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | hydroxychloroquine sulfate | 0093-2401 |
| NCS HealthCare of KY LLC dba Vangard Labs | hydroxychloroquine sulfate | 0615-8374 |
| Rising Pharma Holdings Inc | hydroxychloroquine sulfate | 16571-687 |
| >Company | >Ingredient | >NDC |
hydroxychloroquine sulfate drug variants not containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| NCS HealthCare of KY Inc dba Vangard Labs | hydroxychloroquine sulfate | 0615-8325 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
hydroxychloroquine sulfate drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | hydroxychloroquine sulfate | 0615-8401 |
| Major Pharmaceuticals | hydroxychloroquine sulfate | 0904-7046 |
| Rising Pharma Holdings Inc | hydroxychloroquine sulfate | 16571-112 |
| >Company | >Ingredient | >NDC |
hydroxychloroquine sulfate drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | hydroxychloroquine sulfate | 0093-2401 |
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
hydroxychloroquine sulfate drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | hydroxychloroquine sulfate | 0093-2401 |
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| >Company | >Ingredient | >NDC |
hydroxychloroquine sulfate drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MALTODEXTRIN
hydroxychloroquine sulfate drug variants containing MALTODEXTRIN
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| NCS HealthCare of KY Inc dba Vangard Labs | hydroxychloroquine sulfate | 0615-8325 |
| A-S Medication Solutions | hydroxychloroquine sulfate | 50090-2508 |
| >Company | >Ingredient | >NDC |
hydroxychloroquine sulfate drug variants not containing MALTODEXTRIN
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | hydroxychloroquine sulfate | 0093-2401 |
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| NCS HealthCare of KY LLC dba Vangard Labs | hydroxychloroquine sulfate | 0615-8374 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYDEXTROSE
hydroxychloroquine sulfate drug variants containing POLYDEXTROSE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | hydroxychloroquine sulfate | 0093-2401 |
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| >Company | >Ingredient | >NDC |
hydroxychloroquine sulfate drug variants not containing POLYDEXTROSE
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | hydroxychloroquine sulfate | 0615-8401 |
| NCS HealthCare of KY LLC dba Vangard Labs | hydroxychloroquine sulfate | 0615-8459 |
| Sandoz Inc | hydroxychloroquine sulfate | 0781-1407 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
hydroxychloroquine sulfate drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| NCS HealthCare of KY Inc dba Vangard Labs | hydroxychloroquine sulfate | 0615-8325 |
| >Company | >Ingredient | >NDC |
hydroxychloroquine sulfate drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | hydroxychloroquine sulfate | 0093-2401 |
| NCS HealthCare of KY LLC dba Vangard Labs | hydroxychloroquine sulfate | 0615-8374 |
| NCS HealthCare of KY LLC dba Vangard Labs | hydroxychloroquine sulfate | 0615-8401 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 3350
hydroxychloroquine sulfate drug variants containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | hydroxychloroquine sulfate | 50090-4659 |
| DOH CENTRAL PHARMACY | hydroxychloroquine sulfate | 53808-1112 |
| Amneal Pharmaceuticals NY LLC | hydroxychloroquine sulfate | 60219-1544 |
| >Company | >Ingredient | >NDC |
hydroxychloroquine sulfate drug variants not containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | hydroxychloroquine sulfate | 0093-2401 |
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 400
hydroxychloroquine sulfate drug variants containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Aphena Pharma Solutions - Tennessee LLC | hydroxychloroquine sulfate | 43353-051 |
| A-S Medication Solutions | hydroxychloroquine sulfate | 50090-3432 |
| Advanz Pharma (US) Corp | hydroxychloroquine sulfate | 59212-562 |
| >Company | >Ingredient | >NDC |
hydroxychloroquine sulfate drug variants not containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | hydroxychloroquine sulfate | 0093-2401 |
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 4000
hydroxychloroquine sulfate drug variants containing POLYETHYLENE GLYCOL 4000
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | hydroxychloroquine sulfate | 0615-8401 |
| Accord Healthcare Inc | hydroxychloroquine sulfate | 16729-485 |
| Accord Healthcare Inc | hydroxychloroquine sulfate | 16729-561 |
| >Company | >Ingredient | >NDC |
hydroxychloroquine sulfate drug variants not containing POLYETHYLENE GLYCOL 4000
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | hydroxychloroquine sulfate | 0093-2401 |
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 8000
hydroxychloroquine sulfate drug variants containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | hydroxychloroquine sulfate | 0093-2401 |
| NCS HealthCare of KY LLC dba Vangard Labs | hydroxychloroquine sulfate | 0615-8374 |
| Rising Pharma Holdings Inc | hydroxychloroquine sulfate | 16571-112 |
| >Company | >Ingredient | >NDC |
hydroxychloroquine sulfate drug variants not containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| NCS HealthCare of KY Inc dba Vangard Labs | hydroxychloroquine sulfate | 0615-8325 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
hydroxychloroquine sulfate drug variants containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Aphena Pharma Solutions - Tennessee LLC | hydroxychloroquine sulfate | 43353-051 |
| A-S Medication Solutions | hydroxychloroquine sulfate | 50090-3432 |
| DOH CENTRAL PHARMACY | hydroxychloroquine sulfate | 53808-1112 |
| >Company | >Ingredient | >NDC |
hydroxychloroquine sulfate drug variants not containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | hydroxychloroquine sulfate | 0093-2401 |
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
hydroxychloroquine sulfate drug variants containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | hydroxychloroquine sulfate | 0615-8401 |
| NCS HealthCare of KY LLC dba Vangard Labs | hydroxychloroquine sulfate | 0615-8459 |
| Major Pharmaceuticals | hydroxychloroquine sulfate | 0904-7046 |
| >Company | >Ingredient | >NDC |
hydroxychloroquine sulfate drug variants not containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | hydroxychloroquine sulfate | 0093-2401 |
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
hydroxychloroquine sulfate drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| Sandoz Inc | hydroxychloroquine sulfate | 0781-1407 |
| Sandoz Inc | hydroxychloroquine sulfate | 0781-5994 |
| >Company | >Ingredient | >NDC |
hydroxychloroquine sulfate drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | hydroxychloroquine sulfate | 0093-2401 |
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| NCS HealthCare of KY Inc dba Vangard Labs | hydroxychloroquine sulfate | 0615-8325 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K30
hydroxychloroquine sulfate drug variants containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | hydroxychloroquine sulfate | 0615-8401 |
| Accord Healthcare Inc | hydroxychloroquine sulfate | 16729-485 |
| Accord Healthcare Inc | hydroxychloroquine sulfate | 16729-561 |
| >Company | >Ingredient | >NDC |
hydroxychloroquine sulfate drug variants not containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | hydroxychloroquine sulfate | 0093-2401 |
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
hydroxychloroquine sulfate drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Jubilant Cadista Pharmaceuticals Inc | hydroxychloroquine sulfate | 59746-780 |
| Havix Group Inc d-b-a Aavis Pharmaceuticals | hydroxychloroquine sulfate | 71337-019 |
| >Company | >Ingredient | >NDC |
hydroxychloroquine sulfate drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | hydroxychloroquine sulfate | 0093-2401 |
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| >Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
hydroxychloroquine sulfate drug variants containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Aphena Pharma Solutions - Tennessee LLC | hydroxychloroquine sulfate | 43353-051 |
| A-S Medication Solutions | hydroxychloroquine sulfate | 50090-3432 |
| Jubilant Cadista Pharmaceuticals Inc | hydroxychloroquine sulfate | 59746-780 |
| >Company | >Ingredient | >NDC |
hydroxychloroquine sulfate drug variants not containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | hydroxychloroquine sulfate | 0093-2401 |
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
hydroxychloroquine sulfate drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| NCS HealthCare of KY Inc dba Vangard Labs | hydroxychloroquine sulfate | 0615-8325 |
| A-S Medication Solutions | hydroxychloroquine sulfate | 50090-2508 |
| >Company | >Ingredient | >NDC |
hydroxychloroquine sulfate drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | hydroxychloroquine sulfate | 0093-2401 |
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| NCS HealthCare of KY LLC dba Vangard Labs | hydroxychloroquine sulfate | 0615-8374 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM BICARBONATE
hydroxychloroquine sulfate drug variants containing SODIUM BICARBONATE
| Company | Ingredient | NDC |
|---|---|---|
| Sandoz Inc | hydroxychloroquine sulfate | 0781-1407 |
| Sandoz Inc | hydroxychloroquine sulfate | 0781-5994 |
| Major Pharmaceuticals | hydroxychloroquine sulfate | 0904-6884 |
| >Company | >Ingredient | >NDC |
hydroxychloroquine sulfate drug variants not containing SODIUM BICARBONATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | hydroxychloroquine sulfate | 0093-2401 |
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
hydroxychloroquine sulfate drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| Mylan Institutional Inc | hydroxychloroquine sulfate | 42292-011 |
| A-S Medication Solutions | hydroxychloroquine sulfate | 50090-4659 |
| >Company | >Ingredient | >NDC |
hydroxychloroquine sulfate drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | hydroxychloroquine sulfate | 0093-2401 |
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| NCS HealthCare of KY Inc dba Vangard Labs | hydroxychloroquine sulfate | 0615-8325 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
hydroxychloroquine sulfate drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| NCS HealthCare of KY Inc dba Vangard Labs | hydroxychloroquine sulfate | 0615-8325 |
| A-S Medication Solutions | hydroxychloroquine sulfate | 50090-2508 |
| >Company | >Ingredient | >NDC |
hydroxychloroquine sulfate drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | hydroxychloroquine sulfate | 0093-2401 |
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| NCS HealthCare of KY LLC dba Vangard Labs | hydroxychloroquine sulfate | 0615-8374 |
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
hydroxychloroquine sulfate drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | hydroxychloroquine sulfate | 0093-2401 |
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| NCS HealthCare of KY Inc dba Vangard Labs | hydroxychloroquine sulfate | 0615-8325 |
| >Company | >Ingredient | >NDC |
hydroxychloroquine sulfate drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| Sandoz Inc | hydroxychloroquine sulfate | 0781-1407 |
| Sandoz Inc | hydroxychloroquine sulfate | 0781-5994 |
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, PREGELATINIZED CORN
hydroxychloroquine sulfate drug variants containing STARCH, PREGELATINIZED CORN
| Company | Ingredient | NDC |
|---|---|---|
| NuCare PharmaceuticalsInc | hydroxychloroquine sulfate | 68071-4648 |
| >Company | >Ingredient | >NDC |
hydroxychloroquine sulfate drug variants not containing STARCH, PREGELATINIZED CORN
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | hydroxychloroquine sulfate | 0093-2401 |
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| >Company | >Ingredient | >NDC |
Excipient focus: SUCRALOSE
hydroxychloroquine sulfate drug variants containing SUCRALOSE
| Company | Ingredient | NDC |
|---|---|---|
| Novitium Pharma LLC | hydroxychloroquine sulfate | 70954-172 |
| ANI Pharmaceuticals Inc | hydroxychloroquine sulfate | 70954-804 |
| >Company | >Ingredient | >NDC |
hydroxychloroquine sulfate drug variants not containing SUCRALOSE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | hydroxychloroquine sulfate | 0093-2401 |
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
hydroxychloroquine sulfate drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | hydroxychloroquine sulfate | 0615-8401 |
| NCS HealthCare of KY LLC dba Vangard Labs | hydroxychloroquine sulfate | 0615-8459 |
| Major Pharmaceuticals | hydroxychloroquine sulfate | 0904-7046 |
| >Company | >Ingredient | >NDC |
hydroxychloroquine sulfate drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | hydroxychloroquine sulfate | 0093-2401 |
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
hydroxychloroquine sulfate drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | hydroxychloroquine sulfate | 0093-2401 |
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| >Company | >Ingredient | >NDC |
hydroxychloroquine sulfate drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | hydroxychloroquine sulfate | 50090-5573 |
| >Company | >Ingredient | >NDC |
Excipient focus: TRIACETIN
hydroxychloroquine sulfate drug variants containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | hydroxychloroquine sulfate | 0093-2401 |
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| >Company | >Ingredient | >NDC |
hydroxychloroquine sulfate drug variants not containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | hydroxychloroquine sulfate | 0615-8401 |
| NCS HealthCare of KY LLC dba Vangard Labs | hydroxychloroquine sulfate | 0615-8459 |
| Sandoz Inc | hydroxychloroquine sulfate | 0781-1407 |
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
hydroxychloroquine sulfate drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Novitium Pharma LLC | hydroxychloroquine sulfate | 70954-172 |
| ANI Pharmaceuticals Inc | hydroxychloroquine sulfate | 70954-804 |
| >Company | >Ingredient | >NDC |
hydroxychloroquine sulfate drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | hydroxychloroquine sulfate | 0093-2401 |
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
